DCF

DRUG3 trials

Sponsors

Wakayama Medical University, Xijing Hospital, profdr amira deraz

Conditions

ESCCEsophageal CancerMusculoskeletal Diseases

Phase 1

Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC)

Wakayama Medical UniversityEsophageal Cancer

Start: 2007-08-31End: 2015-08-31Target: 32Updated: 2010-09-09

DEEP NECK FLEXOR STABILIZER BIOFEEDBACK EXERCISE VERSUS INTGREATED NEURO MUSCULAR INHIBITION TECHNIQUE ON CHRONIC MECHANICAL NECK PAIN

Active, not recruitingPACTR202008598885040

profdr amira derazMusculoskeletal Diseases

Start: 2020-08-30Target: 45Updated: 2026-08-03

Unknown Phase

DCF Combined With Camrelizumab in the Treatment of Esophageal Cancer

Xijing HospitalESCC

Start: 2021-09-01End: 2023-12-31Target: 55Updated: 2023-01-31

Related Papers

A phase I/II study of divided-dose docetaxel, cisplatin, and fluorouracil (DCF) for patients with recurrent or metastatic squamous cell carcinoma of the esophagus.

Journal of Clinical Oncology2015-01-20